中国抗体技术出海提速:百奥赛图RenMab获日本专利

华尔街见闻
06 Jun

6月5日,百奥赛图(2315.HK)宣布旗下的全人抗体小鼠RenMice®平台关键技术(下称“RenMice”)获得由日本专利局颁发的发明专利证书。 这是RenMice在全球知识产权保护的关键进展,为百奥赛图出海构建了专利壁垒。 该平台的原理是百奥赛图利用独有的超大片段染色体工程技术,将小鼠的抗体重链和轻链可变区基因原位全区段替换为人的相应基因。由此RenMab小鼠具有完整的人抗体重链VDJ基因和...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10